Bobbi Jo Brockmann serves as Vice President - Sales and Marketing, Director of the Company. Ms. Brockmann served as a Director of the Company from March 2017 to September 2017 and from January 2018 to the present. She was promoted to Vice President of Sales and Marketing in February 2015. She joined the Company as Director of Sales and Marketing in January 2010. Prior to that, she had been employed as Director of Sales since May 2008 and Sales Manager from February 2004 to April 2008 at APC, Inc. of Ankeny, Iowa, a developer and marketer of functional protein products for animal health and nutrition. Prior to that, she held other sales and marketing positions at APC,W & G Marketing Company, Inc. of Ames, Iowa, The Council for Agricultural Science and Technology of Ames, Iowa and Meyocks Group Advertising of West Des Moines, Iowa after graduating from Iowa State University.
As the Vice President - Sales and Marketing e Director of Immucell, the total compensation of Bobbi Brockmann at Immucell is $316,813. There are 2 executives at Immucell getting paid more, with Michael F. Brigham having the highest compensation of $354,272.
Bobbi Brockmann is 44, she's been the Vice President - Sales and Marketing e Director of Immucell since 2018. There are 11 older and no younger executives at Immucell. The oldest executive at Immucell Corp. is Jonathan Rothschild, 66, who is the Independent Director.
Bobbi's mailing address filed with the SEC is 56 Evergreen Dr, Portland, ME 04103, USA.
Over the last 21 years, insiders at Immucell have traded over $168,227 worth of Immucell stock and bought 568,684 units worth $2,330,117 . The most active insiders traders include Jonathan E Rothschild, Norman H Pessin, eJoseph H Crabb. On average, Immucell executives and independent directors trade stock every 50 days with the average trade being worth of $22,979. The most recent stock trade was executed by David Cunningham on 13 June 2022, trading 1,000 units of ICCC stock currently worth $8,000.
immucell corporation is a biotechnology company based out of portland maine. immucell's focus is to create scientifically-proven and practical products that result in a measurable economical impact on animal health and productivity in the dairy and beed industries.
Immucell executives and other stock owners filed with the SEC include: